MIC
TMO icon

Meridian Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History

Meridian Investment Counsel’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-485
Closed -$277K – 228
2021
Q3 		$277K Hold
485
– – 0.1% 174
2021
Q2 		$245K Hold
485
– – 0.09% 179
2021
Q1 		$221K Hold
485
– – 0.09% 177
2020
Q4 		$226K Hold
485
– – 0.1% 165
2020
Q3 		$214K Buy
+485
New +$200K 0.1% 158

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meridian Investment Counsel's TMO Position: Q4 2021 in Review

Meridian Investment Counsel sold out of Thermo Fisher Scientific (TMO) in Q4 2021, closing a stake of 485 shares — an estimated $277K sold.

Meridian Investment Counsel first reported a position in TMO in Q3 2020 and held it in 5 quarters. The position peaked at $277K in Q3 2021. 2,343 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

  • Meridian Investment Counsel reported no remaining Thermo Fisher Scientific position as of Q4 2021 after selling out during the quarter.
  • Meridian Investment Counsel sold 485 Thermo Fisher Scientific shares in Q4 2021, an estimated $277K.
  • Meridian Investment Counsel first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 5 quarters.
  • Meridian Investment Counsel's Thermo Fisher Scientific position peaked at $277K in Q3 2021.
  • 2,343 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on Meridian Investment Counsel's 13F filing for Q4 2021, filed 14 Feb 2022.